Performance and cost-effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity

J Clin Microbiol. 1990 Feb;28(2):303-6. doi: 10.1128/jcm.28.2.303-306.1990.

Abstract

Recent studies have shown that rapid, instrument-free assays for the detection of antibody to human immunodeficiency virus (HIV) can be as sensitive and specific as enzyme-linked immunosorbent assay (ELISA) for screening of donated blood in developing countries. Currently, however, specimens which test positive on a screening assay must still be confirmed by Western blot (immunoblot), a method which is not feasible in most developing-country laboratories. We examined whether a testing hierarchy which utilizes neither conventional ELISA nor Western blot can be reliably used for screening and confirmation of HIV infection in a high-risk population. In a retrospective analysis of 3,878 specimens which were screened for antibody to HIV in Kinshasa, Zaire, we observed that a testing hierarchy consisting of duplicate HIVCHEK screening assays followed by duplicate Serodia-HIV confirmatory assays resulted in correct confirmation of all ELISA- and Western blot-positive specimens. We conclude that such a testing hierarchy can produce highly accurate results for identification of positive specimens in routine HIV testing and provides a practical alternative to conventional methods of HIV screening and confirmation.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blood Donors
  • Blotting, Western
  • Cost-Benefit Analysis
  • Developing Countries
  • Enzyme-Linked Immunosorbent Assay
  • Evaluation Studies as Topic
  • HIV Antibodies / analysis
  • HIV Seropositivity / diagnosis*
  • HIV Seropositivity / immunology
  • HIV-1* / immunology
  • Humans
  • Immunoassay / economics
  • Immunoassay / methods*
  • Mass Screening

Substances

  • HIV Antibodies